Received Nov 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
received only the diluent portion of Shingrix; received only the diluent portion of Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Herpes zoster (Shingrix) for prophylaxis. In OCT-2025, the patient received Shingrix. In OCT-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: received only the diluent portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: received only the diluent portion of Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 22-OCT-2025 A registered nurse had reported that a patient might have received only the diluent portion of Shingrix last week, though they were unsure of the exact date. The nurse was not certain about the gender of the patient or other details such as age or name initials. The nurse had enquired whether the patient had received a full dose, whether revaccination was necessary, and how long they would need to wait. The nurse had asked for recommendations regarding this situation. The batch number was not provided upon follow- up with the reporter